trimethaphan has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DANZIG, LE; GOMEZ, AC | 1 |
| Dushanin, SA; Liashenko, MM; Malaia, LT; Shalimov, AA; Zverev, VV | 1 |
2 other study(ies) available for trimethaphan and Lung Diseases
| Article | Year |
|---|---|
Long-term intravenous use of arfonad in the treatment of pulmonary edema.
Topics: Edema; Humans; Lung Diseases; Pulmonary Edema; Sympatholytics; Trimethaphan | 1954 |
[Catheterization of veins and selective angiopulmonography in comparison with several indices of the functional state of the external respiratory apparatus and blood circulation during chronic lung diseases].
Topics: Adult; Aged; Angiography; Ballistocardiography; Blood Pressure; Capillaries; Carcinoma; Cardiac Catheterization; Catheterization; Chronic Disease; Female; Ganglionic Blockers; Heart; Heart Failure; Hemodynamics; Hexamethonium Compounds; Humans; Hypertension, Pulmonary; Lung Abscess; Lung Diseases; Lung Neoplasms; Male; Methods; Middle Aged; Muscles; Oxygen; Phonocardiography; Pulmonary Artery; Pulmonary Circulation; Pulmonary Emphysema; Pulmonary Fibrosis; Pulmonary Veins; Respiration; Respiratory Insufficiency; Spirometry; Trimethaphan; Tuberculosis, Pulmonary | 1967 |